TCM informs about board meeting

26 May 2018 Evaluate

TCM has informed about the board at their meeting held today has approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2018, and recommend the final dividend of Re 0.30 (i.e. 30%) per equity share of the face value of Re 1 each for the financial year ended 31st March, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

TCM Share Price

60.01 0.01 (0.02%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3752.10
Tata Chemicals 747.25
SRF 3021.45
Pidilite Inds. 1484.15
Deepak Nitrite 1597.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×